Similarly, an association of SEC62 overexpression with lymphatic metastasis was reported for head and neck squamous cell carcinoma [330] as well as an association of SEC62 overexpression with distant metastasis in breast cancer [334]. Here, SEC62 is linked to head and neck squamous cell carcinoma.